Skip to Content

L 12 (Letrozole 2.5 mg)

Pill with imprint L 12 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Lannett Company, Inc..

Letrozole is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L 12

Letrozole

Imprint
L 12
Strength
2.5 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Aromatase inhibitors, Hormones/antineoplastics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lannett Company, Inc.
National Drug Code (NDC)
00527-1712

Get help with Imprint Code FAQs.

Related Images for "L 12"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.